Drug Shortage Report for SANDOZ MONTELUKAST
Report ID | 150164 |
Drug Identification Number | 02330393 |
Brand name | SANDOZ MONTELUKAST |
Common or Proper name | MONTELUKAST |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 5MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 100CHT BO |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-29 |
Estimated end date | 2021-12-17 |
Actual end date | 2021-12-20 |
Shortage status | Resolved |
Updated date | 2021-12-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-12-21 | English | Compare |
v5 | 2021-12-20 | French | Compare |
v4 | 2021-12-20 | English | Compare |
v3 | 2021-11-30 | English | Compare |
v2 | 2021-11-29 | French | Compare |
v1 | 2021-11-29 | English | Compare |
Showing 1 to 6 of 6